[Thymopentin in a case of autoimmune thrombocytopenia secondary to chronic lymphatic leukemia].
The Authors describe a case of chronic lymphocytic leukemia complicated by immune thrombocytopenic purpura. They consider the various causes of thrombocytopenia during lympho-proliferative disorders and underline the different prognostic significance. They evaluate the efficacy of treatment with timopentina.
Cantore
M
M
Bucalossi
A
A
Butini
P
P
Carnevali
A
A
Cavion
M A
MA
Leoncini
L
L
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000209:etiology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008875:Middle Aged; D010446:Peptide Fragments / Q000627:therapeutic use*; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy* / Q000209:etiology; D016305:Thymopentin; D013946:Thymopoietins / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D010446:Peptide Fragments; D013946:Thymopoietins; D013951:Thymus Hormones; D016305:Thymopentin
Timopentina in un caso di piastrinopenia autoimmune secondaria a leucemia linfatica cronica.